Cargando…
Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
Evidence on the link between the immune system and Major Depressive Disorder (MDD) has led to explore antidepressant properties of anti-inflammatory drugs. Among these, minocycline has been identified as a potential novel treatment for MDD, in particular for treatment-resistant depression. The aim o...
Autor principal: | Nettis, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611693/ https://www.ncbi.nlm.nih.gov/pubmed/34568852 http://dx.doi.org/10.1016/j.bbih.2021.100335 |
Ejemplares similares
-
Transdiagnostic biomarker approaches to mental health disorders: Consideration of symptom complexity, comorbidity and context
por: McQuaid, Robyn J.
Publicado: (2021) -
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021) -
Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy
por: Matt, Stephanie M.
Publicado: (2021) -
Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic
por: Lins, Brittney
Publicado: (2021) -
Can (immune and other) gene expression help us to treat depression?
por: Mariani, Nicole
Publicado: (2021)